Stock UniverseDerived research view · source repositories remain read-only

Journey Medical Corporation (DERM)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Speculative
Selection Score
23.41
Global Rank
2987
Market Cap
271.71M
Latest Close
5.97
RS Composite
-22.75% · G#2778

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
14.59%
3M
-23.17%
6M
-22.37%
1Y
-19.87%
3Y
399.58%
5Y
-39.70%
10Y
-39.70%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 116.17K · 30-day average: 242.24K · Max drawdown over stored range: -89.55%

Research Snapshot

Relative Strength vs SPX

RS Composite-22.75%
20D RS18.76%
60D RS-35.99%
120D RS-30.26%
Global RS Rank2778 · 17.20% percentile
Watch+Speculative RS Rank1700 · 18.93% percentile
Group ScopeWatch+Speculative
Primary RS Rank318 · 30.57% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank360 / 701
Primary Percentile48.79
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for DERM.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue44.53163.13473.66979.18156.13461.858
Revenue Growth (YoY)27.519%41.775%16.687%7.482%-29.107%10.197%
Gross Profit29.93737.5542.89456.28835.255
Operating Income7.851-18.841-27.5171.07-13.677
Free Cash Flow5.132-2.181-13.5345.24-9.127-12.441
Free Cash Flow Per Share0.474-0.214-0.7720.287-0.447-0.507837934183371
EPS (Diluted) GAAP0.49-4.319999-1.690008-0.211326-0.71811
EPS Growth36.111%4900%4900%4900%4900%
EPS Non-GAAP
Gross Margin67.227%59.477%58.225%71.088%62.805%66.1741%
Operating Margin17.63%-29.843%-37.352%1.351%-24.365%-13.2109%
Profit Margin11.864%-69.684%-40.218%-4.866%-26.137%-18.4794%
Free Cash Flow Margin11.525%-3.455%-18.371%6.618%-16.259%-20.1122%
Shares Outstanding (Diluted)10.836110.189817.531318.232420.431424.498
Shares Change (YoY)7.546%-5.964%72.047%3.999%12.061%19.904%

SEC Quarterly Fundamentals

No processed quarterly rows for DERM.